Standout Papers

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Coop... 1996 2026 2006 2016 1.5k
  1. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. (1996)
    Marc S. Ernstoff, Thomas J. Smith et al. Journal of Clinical Oncology
  2. Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial (2012)
    Kim Margolin, Marc S. Ernstoff et al. The Lancet Oncology
  3. High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190 (2000)
    John M. Kirkwood, Joseph G. Ibrahim et al. Journal of Clinical Oncology
  4. High-Dose Interferon Alfa-2b Significantly Prolongs Relapse-Free and Overall Survival Compared With the GM2-KLH/QS-21 Vaccine in Patients With Resected Stage IIB-III Melanoma: Results of Intergroup Trial E1694/S9512/C509801 (2001)
    John M. Kirkwood, Joseph G. Ibrahim et al. Journal of Clinical Oncology
  5. Arginase I–Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes (2009)
    Paulo C. Rodrı́guez, Marc S. Ernstoff et al. Cancer Research
  6. Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma (2004)
    David F. McDermott, Meredith M. Regan et al. Journal of Clinical Oncology
  7. Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma (1999)
    Paul B. Chapman, Lawrence H. Einhorn et al. Journal of Clinical Oncology

Immediate Impact

21 by Nobel laureates 17 from Science/Nature 89 standout
Sub-graph 1 of 20

Citing Papers

The β1-adrenergic receptor links sympathetic nerves to T cell exhaustion
2023 StandoutNature
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
1 intermediate paper

Works of Marc S. Ernstoff being referenced

Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity
2020
Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines
2008

Author Peers

Author Last Decade Papers Cites
Marc S. Ernstoff 9864 6514 5080 295 15.5k
Ulrich Keilholz 9074 5711 6046 471 15.1k
Igor Puzanov 10021 3784 6732 300 15.1k
Michele Maio 11151 6794 7186 371 18.0k
Douglas B. Johnson 9445 3922 4462 289 13.5k
Richard Kefford 13685 3916 11485 353 20.1k
John B.A.G. Haanen 13487 10645 6599 424 23.0k
Janice P. Dutcher 6419 3347 6372 268 14.4k
Alfred E. Chang 11203 9573 4135 294 20.5k
Mark R. Middleton 7112 2266 6072 360 13.2k
Adil Daud 10082 5088 7252 308 15.7k

All Works

Loading papers...

Rankless by CCL
2026